Granvalor Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Saidabad, Telangana, India, established in 2011.
2011 Saidabad, Telangana, India Active
Last Updated:
Access Report
About Granvalor Pharmaceuticals Private Limited

Granvalor Pharmaceuticals Private Limited, a active private limited company, was established on 25 March 2011 in Saidabad, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232TG2011PTC073508. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Employing 4 professional, Its leadership includes Khaja Aliuddin (Director), Mohammed Siraj Uddin (Director). Past directors included Hameda Tahseen. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at H.No. 16-9-439/1,, Malakpet,, Saidabad, Telangana, 500036.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TG2011PTC073508

  • Registration Number

    073508

  • Incorporation Date

    25 March 2011

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 15 Year, 6 Days
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 41.96%
  • Profit Growth **** 53.32%
  • Ebitda **** 8.65%
  • Net Worth 28.50%
  • Total Assets **** 7.34%
Company report

Granvalor Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Granvalor Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Granvalor Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Khaja Aliuddin Director 25 Mar 2011 Current
Mohammed Siraj Uddin Director 25 Mar 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Feb 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Granvalor Pharmaceuticals.

Granvalor Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 41.96% increase. The company also saw a substantial improvement in profitability, with a 53.32% increase in profit. The company's net worth Soared by an impressive increase of 28.5%.

Granvalor Pharmaceuticals revenue growth over time
Granvalor Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 41.96%
*******
*******
*******
*******
Revenue from Operations
*******
 41.96%
*******
*******
*******
*******
Total Assets
*******
 7.34%
*******
*******
*******
*******
Profit or Loss
*******
 53.32%
*******
*******
*******
*******
Net Worth
*******
 28.50%
*******
*******
*******
*******
EBITDA
*******
 8.65%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Granvalor Pharmaceuticals?

In 2022, Granvalor Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Granvalor Pharmaceuticals?

Granvalor Pharmaceuticals has a workforce of 4 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Granvalor Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Granvalor Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Granvalor Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Granvalor Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Granvalor Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Director Appointment

    Progress on Khaja Aliuddin was appointed as a Director was appointed as a Director on 25 Mar 2011 & has been associated with this company since 15 years 6 days . was documented.

  • Director Appointment

    The activity Mohammed Siraj Uddin was appointed as a Director was appointed as a Director on 25 Mar 2011 & has been associated with this company since 15 years 6 days . was completed.

  • Company Incorporation

    Progress on Granvalor Pharmaceuticals Private Limited was registered on 25 Mar 2011 with Roc Hyderabad & aged 15 years 6 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Granvalor Pharmaceuticals Private Limited?

The CIN of Granvalor Pharmaceuticals Private Limited is U24232TG2011PTC073508.

Where is Granvalor Pharmaceuticals Private Limited headquartered?

Granvalor Pharmaceuticals Private Limited is headquartered at H.No. 16-9-439/1,, Malakpet,, Saidabad, Telangana, 500036.

When was Granvalor Pharmaceuticals Private Limited incorporated?

Granvalor Pharmaceuticals Private Limited was incorporated on 25 March 2011.

Who are the current directors of Granvalor Pharmaceuticals Private Limited?

The current directors of Granvalor Pharmaceuticals Private Limited are

What is the primary industry of Granvalor Pharmaceuticals Private Limited?

The primary industry of Granvalor Pharmaceuticals Private Limited is Trade.

Is Granvalor Pharmaceuticals Private Limited a listed company?

Granvalor Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Granvalor Pharmaceuticals Private Limited?

The authorized capital of Granvalor Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Granvalor Pharmaceuticals Private Limited?

The compliance status of Granvalor Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available